Nebla, Arnulfo S.
HRN: 17-40-46 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2024
CEFTRIAXONE 1G (VIAL)
08/04/2024
08/10/2024
IV
2g
OD
Choledocholithiases
Waiting Final Action
08/09/2024
AZITHROMYCIN 500MG TABLET (TAB)
08/09/2024
08/13/2024
IM
500mg
OD
CAP MR
Waiting Final Action
08/13/2024
CIPROFLOXACIN 500MG (TAB)
08/13/2024
08/19/2024
ORAL
500mg
BID
UTI
Waiting Final Action